Umoja Biopharma

umoja-biopharma.com

Umoja Biopharma is a biopharmaceutical company focused on developing innovative CAR T-cell therapies that reprogram the immune system in vivo to target and eliminate cancer cells. Their integrated platform therapeutics are designed to treat solid tumors and hematological cancers that are resistant to existing treatments, positioning them at the forefront of cancer immunotherapy. With a commitment to advancing the future of immunotherapy, Umoja aims to extend the benefits of their therapies to every patient in need, leveraging a world-class team of experts and a robust pipeline of treatments.